NCT07131319 2026-02-02
SFRT+Tislelizumab+Platinum Chemotherapy for Unresectable Stage III NSCLC
Second Affiliated Hospital of Nanchang University
Phase 2/3 Recruiting
Clinical Trials
8 trialsNCT05255302 2025-04-01
DIAL
Intergroupe Francophone de Cancerologie Thoracique
Phase 2/3 Recruiting
NCT03380468 2023-07-20
ECTOP-1004
Fudan University
Phase 2/3 Unknown
NCT00651456 2023-03-13
MAPS
Intergroupe Francophone de Cancerologie Thoracique
Phase 2/3 Completed
NCT05209256 2022-01-26
Alflutinib Versus Alflutinib Plus Chemotherapy for NSCLC
The First Affiliated Hospital of Henan University of Science and Technology
Phase 2/3 Unknown
NCT02777788 2017-10-10
TCM
Shanghai University of Traditional Chinese Medicine
Phase 2/3 Unknown
NCT01769066 2016-02-23
Clinical Value of Sequential Gefitinib With Pemetrexed/Platinum for Advanced NSCLC
Fudan University
Phase 2/3 Completed
NCT01481259 2012-07-03
Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Nonsquamous Non-small Cell Lung Cancer
People's Hospital of Guangxi Zhuang Autonomous Region
Phase 2/3 Unknown